ArticleJournal of neurology2026

Tocilizumab for severe immune checkpoint inhibitor myopathy-myocarditis: acute and long-term outcomes.

Gurpreet Chaggar et al.PubMed ↗Publisher ↗

No numbers read from the abstract.